How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Purdue’s Presidential Lecture Series is a cornerstone of the intellectually vibrant community of scholars on our campus. Universities are places where ideas compete and curious minds gather, ...

ACS Interactions brings programs and sessions on innovation, skill development, and scientific discussions. This diverse program features curated scientific discussions, thought-provoking leadership ...

Mark Carney, former Governor of the Bank of England, argues that changing attitudes to value and the marketplace have contributed to a trio of crises: credit, Covid and climate. Why have financial ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Three hours of lecture/discussion per week. Algebraic operations on polynomials and rational functions as expressions, in equations, or inequalities. Graphing of linear and polynomial equations. An ...